• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,658.24 149.83
(0.29%)
Dow Jones
7,594.79 30.15
(0.40%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Valiant Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543998
INE0JWS01017
58.8745685
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VALIANTLAB
61
337.93
EPS(TTM)
Face Value()
Div & Yield %
1.02
10
0
 

viji finance ltd
JOJO consolidated net profit rises 7883.33% in the March 2026 quarter
May 16,2026
Net profit of JOJO rose 7883.33% to Rs 4.79 crore in the quarter ended March 2026 as against Rs 0.06 crore during the previous quarter ended March 2025. Sales rose 781.12% to Rs 12.60 crore in the quarter ended March 2026 as against Rs 1.43 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 5.62 crore in the year ended March 2026 as against net loss of Rs 1.66 crore during the previous year ended March 2025. Sales rose 446.92% to Rs 24.01 crore in the year ended March 2026 as against Rs 4.39 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales12.601.43 781 24.014.39 447
OPM %48.10-67.83 -42.69-18.45 -
PBDT5.64-0.98 LP 10.720.67 1500
PBT5.120.12 4167 9.08-0.56 LP
NP4.790.06 7883 5.62-1.66 LP